Arcturus Therapeutics Holdings Inc. (ARCT) Profit Margins
Over the twelve months to 2026-06-30, Arcturus Therapeutics Holdings Inc. (ARCT) had operating margin -348.3%, net margin -317.6%, free cash flow margin -248.0%, according to EquiReason's reading of its SEC filings.
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
ARCTArcturus Therapeutics Holdings Inc.Follow ARCT — free
—
Price chart with a free account
- Market cap
- 279.7M
- P/E TTM
- —
- Dividend yield
- —
- 52-week
- —
- Next earnings
- 11 Nov, in 18 days
| Line | FY2019 Dec 19 | FY2020 Dec 20 | FY2021 Dec 21 | FY2022 Dec 22 | FY2023 Dec 23 | FY2024 Dec 24 | FY2025 Dec 25 | TTM Jun 26 | Trend |
|---|---|---|---|---|---|---|---|---|---|
| Operating margin | -122.7% | -749.8% | -1641.3% | 5.9% | -46.9% | -62.8% | -93.0% | -348.3% | |
| Net margin | -125.0% | -756.3% | -1648.0% | 4.5% | -17.8% | -53.1% | -80.2% | -317.6% | |
| FCF margin | -34.9% | -467.6% | -1120.2% | 11.8% | -12.6% | -39.7% | -90.8% | -248.0% |
USD millions · SEC XBRL
Arcturus Therapeutics Holdings Inc. — questions
- What is Arcturus Therapeutics Holdings Inc.'s operating margin?
- -348.3% over the twelve months to 2026-06-30.
- What is Arcturus Therapeutics Holdings Inc.'s net profit margin?
- -317.6% over the twelve months to 2026-06-30.
Every figure on this page comes from Arcturus Therapeutics Holdings Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.